OAS3 and COVID-19: In our study, individuals carrying the heterozygous C/T genotype of the OAS3 gene variant rs2285932 were at a 50% reduced risk of developing COVID-19 symptoms compared to those without this genotype (OR = 0.50; 95% CI: 0.19–1.31).